Market Place
Sourcing Support
CBD Life Sciences Positioned For Growth Amid Legalization
24 Oct 2024 //
GLOBENEWSWIRE
CBD Life Sciences Launches CBD Horse Paste For Equine Wellness
03 Oct 2024 //
ACCESSWIRE
CBD Life Sciences Expands Revenue Stream With RangeMe
02 Oct 2024 //
ACCESSWIRE
CBD Life Sciences Targets Amazon For Business Growth
01 Oct 2024 //
ACCESSWIRE
CBD Life Sciences Unveils Nutritional Supplement Infused With Mushroom Extracts
17 Sep 2024 //
ACCESSWIRE
Jazz Pharma Presents Data on Epidiolex® at European Epilepsy Congress 2024
05 Sep 2024 //
PR NEWSWIRE
Brains Bioceutical Nears CEP For Cannabidiol Certification In Europe
22 Aug 2024 //
GLOBENEWSWIRE
Jazz Pharma Updates On Cannabidiol Trial In Japan For Epilepsy
22 Aug 2024 //
PR NEWSWIRE
SciSparc Enrolls First Five Patients In SCI-210 Treatment Clinical Trial
19 Aug 2024 //
GLOBENEWSWIRE
EmpowerPharm Announces Phase 2 CBD Trial Outcome For Social Anxiety Disorder
06 Jun 2024 //
PR NEWSWIRE
LRP-661 CBD Progress At ETDD Miami Conference
15 Apr 2024 //
GLOBENEWSWIRE
Harmony buys cannabidiol firm Zynerba in $200m deal
16 Aug 2023 //
PHARMAPHORUM
Transo-Pharm Partners With 22nd Century For Global Cannabinoid API Distribution
23 Jan 2023 //
PRESS RELEASE
Jazz sues generics for infringement on cannabis-derived drug
06 Jan 2023 //
FIERCE PHARMA
Virpax Pharma Reports on FDA Pre-IND Response for NobrXiol™ (formerly VRP324)
14 Dec 2022 //
BUSINESSWIRE
FDA Confirms Paragraph IV Patent Litigation for Cannabidiol Oral Solution
14 Dec 2022 //
FDA
Jazz Pharma Presents New Findings From Caregiver Survey on Outcomes of Epidiolex
05 Dec 2022 //
PRESS RELEASE
PureTech readies oral CBD capsule for clinic to challenge Jazz
01 Dec 2022 //
FIERCEPHARMA
Zynerba Announces EC Has Granted Orphan Drug Designation for Zygel
15 Nov 2022 //
GLOBENEWSWIRE
Zynerba Announces Issuance of New U.S. Patent for Zygel
02 Nov 2022 //
ZYNERBA
Isosceles Signs Letter of Intent With Partner for PI Development of Cannabidiol
31 Oct 2022 //
PRNEWSWIRE
Jazz Pharma Initiates PIII Trial of Epidiolex/Epidyolex in Epilepsy
18 Aug 2022 //
PRNEWSWIRE
Virpax Pharmaceuticals Reports 2022 Second Quarter Results
15 Aug 2022 //
BUSINESSWIRE
InMed to Supply Rare Cannabinoids to Radicle Science`s Radicle Energy Study
05 May 2022 //
GLOBENEWSWIRE
MGC Pharma, Sciensus Rare Partner for Distribution of Cannabinoids
05 Apr 2022 //
PRNEWSWIRE
Orcosa on Positive Results of NYU Langone’s Phase 1/2 Trial Utilizing ORAVEXX
25 Mar 2022 //
BUSINESSWIRE
Panacea Life Sciences Partners with European CBD Market Leader for US Launch
15 Mar 2022 //
ACCESSWIRE
Can-Fite’s Findings in the Treatment of Liver Diseases with Cannabinoids
11 Mar 2022 //
BUSINESSWIRE
Can B Corp., American Development Partners Agree to Finance, Develop CBD Lounges
08 Mar 2022 //
ACCESSWIRE
Artelo Bags Notice of Allowance for Method-of-Use Patent in U.S. for ART12.11
02 Mar 2022 //
GLOBENEWSWIRE
Brains Bioceutical Initiates Clinical Trial Agreement To Tackle Opioid Addiction
09 Feb 2022 //
PRNEWSWIRE
Love Hemp Group PLC Announces Directorate Changes
03 Feb 2022 //
ACCESSWIRE
Skye Bioscience Reports Potential Neuroprotective Benefit of SBI-100
01 Feb 2022 //
GLOBENEWSWIRE
Canntab Announces Closing Of Convertible Debenture Private Placement
01 Feb 2022 //
PRNEWSWIRE
InMed Launches CBT Expanding its Rare Cannabinoid Portfolio
19 Jan 2022 //
GLOBENEWSWIRE
Avicanna Enters Master Supply Agreement with Chilean Pharmaceutical
14 Jan 2022 //
GLOBENEWSWIRE
SciSparc Issued U.S. Patent For Its Core Technology That Treats Central Nervous Systems Disorders
04 Jan 2022 //
PRESS RELEASE
ANANDA Scientific Announces FDA approval of IND for Trial on Opioid Use Disorder
04 Jan 2022 //
BUSINESSWIRE
Malachite Innovations Announces Two Granted U.S. Patents & New PCT Patent Filing
28 Dec 2021 //
GLOBENEWSWIRE
GW Pharma gets nod for reimbursement of Epidyolex
17 Dec 2021 //
PHARMABIZ
IGC`s Alzheimer Trial Indicates +ve Safety, Tolerability Data for THC-Based IND
14 Dec 2021 //
BUSINESSWIRE
VPR Brands Gets Favorable Settlement of Recently Filed Patent Infringement Case
07 Dec 2021 //
PRNEWSWIRE
GW Pharma gets approval for reimbursement of Epidyolex from Ireland’s
06 Dec 2021 //
PHARMABIZ
Cibdol Launches Revolutionary CBD Oil Formula
05 Dec 2021 //
PRNEWSWIRE
Jazz to Present from Expanding Neuroscience, Epidiolex Oral Solution Data
01 Dec 2021 //
PRNEWSWIRE
Enveric Announces Positive Preclinical Data for EV102 Radiodermatitis Candidate
18 Nov 2021 //
BIOSPACE
ZYUS Life Sciences Launches New Medical Cannabinoid Formulation in Canada
17 Nov 2021 //
BUSINESSWIRE
Aurora Launches new genetics licensing business unit- Occo
16 Nov 2021 //
PRNEWSWIRE
Aurora Cannabis Announces Fiscal 2022 First Quarter Results
09 Nov 2021 //
PRNEWSWIRE
Curebase, LEVEL Announce Clinical Trial to Determine Cannabinoids aided sleep
03 Nov 2021 //
PRNEWSWIRE
Lygos Completes Commercial-Scale Fermentation Campaign of Bio-based Cannabinoids
27 Oct 2021 //
BUSINESSWIRE
Texas` Delta 8 ban faces new legal challenge from Houston vape shop
26 Oct 2021 //
CHRON
Nalu Bio Secures Global Supply Chain to Chemically Synthesize CBD
26 Oct 2021 //
PRNEWSWIRE
Cannabidiol asset in hospitalised Covid-19: trial to complete by year’s end
07 Oct 2021 //
CLINICALTRIALSARENA
MyMD to Detail its Two Upcoming Phase 2 Trials at Benzinga Rising Stars
05 Oct 2021 //
BUSINESSWIRE
Cannabics Announces New Corporate Logo, New Website and New Company Presentation
30 Sep 2021 //
PRNEWSWIRE
ANANDA Scientific & David Geffen School of Medicine UCLA to evaluate CBD for OUD
29 Sep 2021 //
BUSINESSWIRE
Avicanna Files US Patent Application for a Novel Cannabinoid Formulation
24 Sep 2021 //
GLOBENEWSWIRE
Virpax to Develop Intranasal Cannabidiol Product for the Management of Epilepsy
20 Sep 2021 //
BUSINESSWIRE
